Aprea Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APRE research report →
About the company
Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways.
- CEO
- Oren Gilad
- IPO
- 2019
- Employees
- 8
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $4.81M
- P/E
- -0.48
- P/S
- 40.75
- P/B
- 0.13
- EV/EBITDA
- 3.49
- Div Yield
- 0.00%
- Gross Margin
- -1523.59%
- Op Margin
- -10649.87%
- Net Margin
- -10121.69%
- ROE
- -59.54%
- ROIC
- -29.38%
- Revenue
- $0 · -100.00%
- Net Income
- $-12,599,569 · 2.77%
- EPS
- $-1.93 · 17.87%
- Op Income
- $-13,233,836
- FCF YoY
- 4.99%
- 52W High
- $2.22
- 52W Low
- $0.55
- 50D MA
- $0.83
- 200D MA
- $0.98
- Beta
- 1.56
- Avg Volume
- 209.72K
Get TickerSpark's AI analysis on APRE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | Grissinger Michael | other | 12,555 |
| Jun 16, 26 | Grissinger Michael | other | 3,135 |
| Jun 16, 26 | Gruia Gabriela | other | 12,555 |
| Jun 16, 26 | Gruia Gabriela | other | 3,135 |
| Jun 16, 26 | Peters Richard | other | 12,555 |
| Jun 16, 26 | Peters Richard | other | 3,135 |
| Jun 16, 26 | HENNEMAN JOHN B III | other | 3,135 |
| Jun 16, 26 | HENNEMAN JOHN B III | other | 12,555 |
| Jun 16, 26 | BIZZARI JEAN-PIERRE | other | 12,555 |
| Jun 16, 26 | BIZZARI JEAN-PIERRE | other | 3,135 |
Our APRE coverage
Recent articles, reports, and earnings notes.
No research on APRE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate APRE report →Similar companies
Peers in the same neighborhood.